Literature DB >> 27082658

Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.

Klécia M S M Cassemiro1, Fernanda M Burlandy1, Edson E da Silva1.   

Abstract

A natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus was isolated from an acute flaccid paralytic case in Brazil. Genome sequencing revealed the uncommon location of the crossover site in the VP1 coding region (nucleotides 3251-3258 of Sabin 3 genome). The Sabin 2 donor sequence replaced the last 118 nt of VP1, resulting in the substitution of the complete antigenic site IIIa by PV2-specific amino acids. The low overall number of nucleotide substitutions in P1 region indicated that the predicted replication time of the isolate was about 8-9 weeks. Two of the principal determinants of attenuation in Sabin 3 genomes were mutated (U472C and C2493U), but the temperature-sensitive phenotype of the isolate was preserved. Our results support the theory that there exists a PV3/PV2 recombination hotspot site in the tail region of the VP1 capsid protein and that the recombination may occur soon after oral poliovirus vaccine administration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27082658     DOI: 10.1099/jgv.0.000484

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Acute flaccid paralysis laboratorial surveillance in a polio-free country: Brazil, 2005-2014.

Authors:  Ivanildo P Sousa; Fernanda M Burlandy; Silas S Oliveira; Amanda M Nunes; Cristiane Sousa; Elaine M da Silva; Jaqueline G A Souza; Valdemar A de Paula; Ivone C M Oliveira; Fernando Neto Tavares; Eliane V da Costa; Edson Elias da Silva
Journal:  Hum Vaccin Immunother       Date:  2016-11-30       Impact factor: 3.452

2.  Molecular characterization and epidemiological aspects of non-polio enteroviruses isolated from acute flaccid paralysis in Brazil: a historical series (2005-2017).

Authors:  Ivanildo P Sousa; Maria de Lourdes Aguiar Oliveira; Fernanda M Burlandy; Raiana S Machado; Silas S Oliveira; Fernando N Tavares; Francisco Gomes-Neto; Eliane V da Costa; Edson E da Silva
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.